Archive - June 2020
BMS scores EU okay for first-in-class anaemia drug Reblozyl
Novartis pulls EU filing for $3.4bn eye therapy Xiidra
Vertex’s triple CF therapy scores recommendation from CHMP
Obesity linked to higher risk of dementia
Successful Elocta bid should widen access to the drug in the UK
Successful Eloctaq bid should widen access to the drug in the UK
EC clears new class of anaemia therapy
Eight medicines leap towards EU approval